This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
Revolutionising quality control In the backdrop of stringent quality standards and regulatory demands inherent to pharmaceuticalmanufacturing, the addition of AI technologies introduce a paradigm shift. Integrative Analysis of Multi-Omics Data with Deep Learning: Challenges and Opportunities in Bioinformatics.
The regulatory environment in Japan for generic drugdevelopment is complex and has undergone significant changes in recent years. New Drug Application (NDA) : Needed for marketing approval of new drugs. Abbreviated New Drug Application (ANDA) : Required for marketing approval of generic drugs.
The US Food and Drug Administration (FDA) has released a discussion paper to complement and inform future guidance on artificial intelligence (AI) and machine learning (ML) in drugdevelopment. The paper also highlighted that AI/ML can enhance manufacturing supply chain. Comment on the discussion paper here.
They can help ensure that these submissions are complete, accurate, and timely, which is critical for advancing drugdevelopment programs. They can help ensure that the commercial pharmaceuticalmanufacturing process is designed to meet regulatory requirements and offer insight into the most effective manufacturing strategies.
To address growing demand from the pharmaceutical industry, Asahi Kasei has launched a new division, Asahi Kasei Life Science, effective from 1 April 2025. The new structure is designed to unify its bioprocess businesses and streamline services offered to pharmaceutical partners across drugdevelopment and manufacturing.
The first in our inaugural Pharma Horizons report series is dedicated to exploring the latest advances in artificial intelligence (AI) and machine learning (ML) for drugdevelopment, pharmaceuticalmanufacturing and quality control.
Carbon contributing factors: The mitigating factors throughout the drugdevelopment process The carbon-contributing factors in the production and distribution of Capsugel capsules at Lonza can be categorised into three main areas: upstream, operational, and downstream activities.
Panelists emphasised the importance of skilled manpower, regular cleaning verification studies, and the application of machine learning in pharmaceuticalmanufacturing. They also addressed data integrity, GDPR, and the need for change control in product manufacturing.
Delpharm has acquired the Meppel pharmaceuticalmanufacturing facility in the Netherlands from Astellas. The acquisition will strengthen the CDMO’s position in the Netherlands, where it already owns a manufacturing facility in Bladel and an injectable drugdevelopment centre in Leiden. billion in 2024.
The FDA has released 25 new product specific guidances (PSG) and 21 newly-revised PSGs that the agency provides to assist generic pharmaceuticalmanufacturers to developdrugs and generate the evidence needed to support ANDA approvals.
Richardson, who focuses her practice on state and federal regulatory strategy and compliance, primarily for pharmaceuticalmanufacturers and wholesale distributors, has been with the firm 7 years and has proven herself invaluable to colleagues and clients alike. Kalie is the quintessential HPM lawyer.
When establishing or expanding services to support new drugdevelopment, pharmaceutical and biotech companies find that automating their processes increases efficiency, maximizes capital, reduces costs, and expedites time-to-market.
This flexibility is particularly beneficial for pharmaceuticalmanufacturers looking to upgrade their research and discovery processes without overhauling their entire systems. “Great thanks to Pharmaceutical Technology.
This depth of talent enables Indian CDMOs to offer more than just capacitythey bring scientific capability to the table, a critical factor as drugdevelopment becomes increasingly complex. Regulatory and government support Indias government has moved decisively to support pharmaceuticalmanufacturing.
Despite the current emphasis on biologic medicines, small molecule drugs still dominate the pharmaceuticalmanufacturing world. Within the small molecule landscape, several trends are shaping the industry’s future, one of the most notable being the rise of high-potency active pharmaceutical ingredients (HPAPIs).
We are focused on developing tools and resources that help companies navigate this issue and enhancing our knowledge of how regulators are enforcing current AI limits. Before the COVID pandemic, industry issues like this were often dealt with in a silo.
James is recognized as helping fundamentally shift the culture to consider the patient voice as an integral part of drugdevelopment. Mr. Karst, a co-author of the FDA Law Blog, provides regulatory counsel to pharmaceuticalmanufacturers on Hatch-Waxman patent and exclusivity, drugdevelopment, pediatric testing, and orphan drugs.
What are the top 3 trends that defined pharma manufacturing in India and globally in 2024? In 2024, the pharmaceuticalmanufacturing landscape underwent transformative changes, driven by technological innovations, regulatory adaptations, and evolving global demands.
Paradigm Shift in DrugDevelopment: Analytical Quality by Design and Analytical Procedure Life Cycle In today’s pharmaceuticalmanufacturing environment, companies face increasing pressure to respond to changing demands across the global medicines supply chain while still maintaining the quality of their drug products.
Navigating the complex landscape of drugdevelopment and manufacturing can be a daunting task. Enter the Contract Development and Manufacturing Organization (CDMO) a lifeline for many startups looking to bring their innovative therapies to market. How can you ensure your CDMO is up to scratch?
Power of collaboration more pertinent than ever says pharma experts Sectors Sections Clinical Trials DrugManufacturers Therapy Area Pricing and Market Access Latest Madrigal poised to enter European MASH market after CHMP endorsement Novartis’ ribociclib approved in Canada for early breast cancer NSW government invests $13.39m in life-changing therapies (..)
Power of collaboration more pertinent than ever says pharma experts Sectors Sections Clinical Trials DrugManufacturers Therapy Area Pricing and Market Access Latest UK and US governments pursue contrasting vaccine strategies Eli Lilly and Eisai’s Alzheimer’s drugs denied NHS use due to high costs Draig secures $140m for neuropsychiatric disorder therapies (..)
Power of collaboration more pertinent than ever says pharma experts Sectors Sections Clinical Trials DrugManufacturers Therapy Area Pricing and Market Access Latest Madrigal poised to enter European MASH market after CHMP endorsement Novartis’ ribociclib approved in Canada for early breast cancer NSW government invests $13.39m in life-changing therapies (..)
Power of collaboration more pertinent than ever says pharma experts Sectors Sections Clinical Trials DrugManufacturers Therapy Area Pricing and Market Access Latest Madrigal poised to enter European MASH market after CHMP endorsement Novartis’ ribociclib approved in Canada for early breast cancer NSW government invests $13.39m in life-changing therapies (..)
Actio Biosciences CEO and co-founder David Goldstein stated: “We have made tremendous progress across our pipeline – executing a precision medicine strategy that targets the root causes of disease through genetically informed drugdevelopment.
Kisunla and Leqembi were touted as the most promising treatments to emerge from Alzheimer’s drugdevelopment in recent times. However, side effects from the drugs can be serious, and their high cost has been a barrier to reimbursement.
Located on the outskirts of the historic Italian city – home to Verdi and myriad architectural gems – the press launch and tour of the €85 million Chiesi development was a quintessentially Italian affair, based out of Chiesi’s San Leonardo production site. In-house drugdevelopment of biologicals and rare disease targeting.
Kurt provides regulatory counsel to pharmaceuticalmanufacturers on Hatch-Waxman patent and exclusivity, drugdevelopment, pediatric testing, and orphan drugs.
Power of collaboration more pertinent than ever says pharma experts Sectors Sections Clinical Trials DrugManufacturers Therapy Area Pricing and Market Access Latest Novo Nordisk seeks digital health partners to boost GLP-1RA weight loss outcomes Orion and Glykos extend ADC collaboration Ex-ACIP panel warns of ‘critically weakened’ US immunisation (..)
Sectors Sections Clinical Trials DrugManufacturers Therapy Area Pricing and Market Access Latest Bayer’s Eylea market grip set to slip as Alvotech biosimilar closes in Harbour BioMed partners Otsuka on new T-cell therapy Madrigal poised to enter European MASH market after CHMP endorsement Themes Sections Artificial Intelligence Cloud Corporate Governance (..)
Power of collaboration more pertinent than ever says pharma experts Sectors Sections Clinical Trials DrugManufacturers Therapy Area Pricing and Market Access Latest Novo Nordisk seeks digital health partners to boost GLP-1RA weight loss outcomes Orion and Glykos extend ADC collaboration Ex-ACIP panel warns of ‘critically weakened’ US immunisation (..)
Sectors Sections Clinical Trials DrugManufacturers Therapy Area Pricing and Market Access Latest Bayer’s Eylea market grip set to slip as Alvotech biosimilar closes in Harbour BioMed partners Otsuka on new T-cell therapy Madrigal poised to enter European MASH market after CHMP endorsement Themes Sections Artificial Intelligence Cloud Corporate Governance (..)
The potential to use these scientific breakthroughs to make a real difference to patients’ lives is what drives many highly skilled scientists to the world of drugdevelopment. Yet commercialising a drug is no easy journey, hence why just 10% of new drug candidates succeed in making it to market.
Power of collaboration more pertinent than ever says pharma experts Sectors Sections Clinical Trials DrugManufacturers Therapy Area Pricing and Market Access Latest Novo Nordisk seeks digital health partners to boost GLP-1RA weight loss outcomes Orion and Glykos extend ADC collaboration Ex-ACIP panel warns of ‘critically weakened’ US immunisation (..)
Commercial dose companies form a critical component of the pharmaceuticalmanufacturing industry’s value chain. The dose form manufacturing follows API manufacturing to produce the final dosage form (FDF such as tablets and injectables.
Sectors Sections Clinical Trials DrugManufacturers Therapy Area Pricing and Market Access Latest Bayer’s Eylea market grip set to slip as Alvotech biosimilar closes in Harbour BioMed partners Otsuka on new T-cell therapy Madrigal poised to enter European MASH market after CHMP endorsement Themes Sections Artificial Intelligence Cloud Corporate Governance (..)
The list includes suppliers of a wide range of pharmaceutical packaging, containers and containment solutions, including plastic, glass and other customised packaging solutions, as well as labelling and printing solutions.
Name Email Phone Number Company Department State City 1 / 15 How does analytics support adherence to regulatory guidelines in the Indian pharmaceuticalmanufacturing sector? 2 / 15 In the Indian pharmaceutical industry, what does analytics-driven supply chain management primarily focus on?
2 However, most of these efforts relating to catalysis, 3 process waste metrics, 4 lifecycle assessments, 5 pharmaceuticals in the environment 6 and the phase out of substances of concern 7 mainly mitigate the consequences of pharmaceuticalmanufacturing. Defossilization of pharmaceuticalmanufacturing.
Power of collaboration more pertinent than ever says pharma experts Sectors Sections Clinical Trials DrugManufacturers Therapy Area Pricing and Market Access Latest Madrigal poised to enter European MASH market after CHMP endorsement Novartis’ ribociclib approved in Canada for early breast cancer NSW government invests $13.39m in life-changing therapies (..)
From the Human Genome Project to contemporary drugdevelopment, collaboration is critical to the life sciences. It is also an important factor in the success of life sciences clusters, where a high concentration of pharmaceutical or medical device companies can all be found in one district, city or region.
In recent years, the pharmaceutical industry has exhibited a significant shift into digitalisation, with AI pushing for innovation across the entire drugdevelopment value chain, from accelerating drug discovery to optimising clinical trial design to ultimately improve patient outcomes.
The move to component management has dramatic implications for pharmaceuticalmanufacturers. Coupling data with documents can save hours spent on data quality control for submission documents. Companies increasingly recognize the need to adopt technologies such as artificial intelligence (AI) to assist with this paradigm shift.
14 In addition, sponsors should ensure that the datasets used to develop AI models reflect the intended patient population and disease variations. 15 ,16 Failure to do so risks overlooking meaningful variability and could reinforce historical limitations in drugdevelopment.
We organize all of the trending information in your field so you don't have to. Join 11,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content